New blood prep tool could make cancer detection easier
NCT ID NCT05942066
First seen Feb 15, 2026 · Last updated Jun 23, 2026 · Updated 23 times
Summary
This study tests a new device called See.d that processes whole blood into slides and plasma for liquid biopsy. Researchers want to see if the device can standardize sample preparation, making it easier to detect cancer cells or DNA in the blood. The study involves 200 healthy adults and focuses on the quality and stability of the processed samples.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ospedale San Raffaele
RECRUITINGMilan, 20132, Italy
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could make liquid biopsies more reliable and easier to use for detecting diseases like cancer from a blood sample.
What could go wrong
This is an early feasibility study with healthy volunteers, not patients. It only tests the device's ability to process blood, not to diagnose or treat any disease.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.